US Stock MarketDetailed Quotes

NYMXF Nymox Pharmaceutical

Watchlist
  • 0.080
  • -0.030-27.27%
15min DelayClose Jan 24 16:00 ET
7.48MMarket Cap-0.80P/E (TTM)

Nymox Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0.00%-5K
0
0
0
0
0.00%-5K
0
0
Operating revenue
--0
--0
0.00%-5K
--0
--0
--0
--0
0.00%-5K
--0
--0
Cost of revenue
0
0
0
0
0
0
0
0
Gross profit
0
0
0
0
0
0.00%-5K
0
0
Operating expense
-35.60%653K
25.53%8.35M
387.66%4.85M
-31.53%1.01M
-38.06%1.1M
-72.70%1.39M
-46.80%6.65M
-160.47%-1.69M
-55.09%1.48M
-55.42%1.78M
Selling and administrative expenses
-59.77%142K
51.30%4.36M
390.47%2.83M
-40.07%353K
-47.62%506K
-10.14%665K
-50.75%2.88M
-60.51%577K
-59.63%589K
-49.58%966K
-Selling and marketing expense
--0
----
----
--0
--0
----
----
----
--0
--0
-General and administrative expense
-59.77%142K
51.30%4.36M
390.47%2.83M
-40.07%353K
-47.62%506K
-10.14%665K
-50.75%2.88M
-60.51%577K
-59.63%589K
-49.58%966K
Research and development costs
-22.69%511K
5.86%3.99M
189.26%2.02M
-25.90%661K
-26.67%594K
-83.39%720K
-43.33%3.77M
-270.54%-2.26M
-51.50%892K
-60.83%810K
Operating profit
35.60%-653K
-25.53%-8.35M
-388.82%-4.86M
31.53%-1.01M
38.06%-1.1M
72.70%-1.39M
46.80%-6.65M
160.19%1.68M
55.09%-1.48M
55.42%-1.78M
Net non-operating interest income expense
-186.36%-63K
-30.95%-55K
15.38%-22K
-120.00%-22K
-900.00%-10K
83.33%-2K
-35.48%-42K
-30.00%-26K
-10K
83.33%-1K
Non-operating interest income
----
500.00%6K
----
----
----
--2K
-87.50%1K
----
----
----
Non-operating interest expense
----
41.86%61K
----
----
----
-66.67%2K
10.26%43K
----
----
----
Total other finance cost
186.36%63K
----
----
120.00%22K
900.00%10K
-66.67%2K
----
----
--10K
-83.33%1K
Other net income (expense)
-472.03%-439K
6,000.00%118K
-3M
3.12M
Gain on sale of security
----
-80.00%1K
----
----
----
----
350.00%5K
----
----
----
Special income (charges)
----
---440K
----
----
----
----
----
----
----
----
-Less:Other special charges
----
--440K
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
----
--113K
---3M
----
--3.12M
Income before tax
30.89%-716K
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
30.89%-716K
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
Net income continuous Operations
30.89%-716K
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
Minority interest income
Net income attributable to the parent company
30.89%-716K
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
30.89%-716K
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
133.58%1.34M
Basic earnings per share
0.00%-0.01
-42.86%-0.1
-500.00%-0.06
50.00%-0.01
-200.00%-0.01
66.67%-0.02
53.33%-0.07
66.67%-0.01
50.00%-0.02
120.00%0.01
Diluted earnings per share
0.00%-0.01
-42.86%-0.1
-500.00%-0.06
50.00%-0.01
-200.00%-0.01
66.67%-0.02
53.33%-0.07
66.67%-0.01
50.00%-0.02
120.00%0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 000.00%-5K00000.00%-5K00
Operating revenue --0--00.00%-5K--0--0--0--00.00%-5K--0--0
Cost of revenue 00000000
Gross profit 000000.00%-5K00
Operating expense -35.60%653K25.53%8.35M387.66%4.85M-31.53%1.01M-38.06%1.1M-72.70%1.39M-46.80%6.65M-160.47%-1.69M-55.09%1.48M-55.42%1.78M
Selling and administrative expenses -59.77%142K51.30%4.36M390.47%2.83M-40.07%353K-47.62%506K-10.14%665K-50.75%2.88M-60.51%577K-59.63%589K-49.58%966K
-Selling and marketing expense --0----------0--0--------------0--0
-General and administrative expense -59.77%142K51.30%4.36M390.47%2.83M-40.07%353K-47.62%506K-10.14%665K-50.75%2.88M-60.51%577K-59.63%589K-49.58%966K
Research and development costs -22.69%511K5.86%3.99M189.26%2.02M-25.90%661K-26.67%594K-83.39%720K-43.33%3.77M-270.54%-2.26M-51.50%892K-60.83%810K
Operating profit 35.60%-653K-25.53%-8.35M-388.82%-4.86M31.53%-1.01M38.06%-1.1M72.70%-1.39M46.80%-6.65M160.19%1.68M55.09%-1.48M55.42%-1.78M
Net non-operating interest income expense -186.36%-63K-30.95%-55K15.38%-22K-120.00%-22K-900.00%-10K83.33%-2K-35.48%-42K-30.00%-26K-10K83.33%-1K
Non-operating interest income ----500.00%6K--------------2K-87.50%1K------------
Non-operating interest expense ----41.86%61K-------------66.67%2K10.26%43K------------
Total other finance cost 186.36%63K--------120.00%22K900.00%10K-66.67%2K----------10K-83.33%1K
Other net income (expense) -472.03%-439K6,000.00%118K-3M3.12M
Gain on sale of security -----80.00%1K----------------350.00%5K------------
Special income (charges) -------440K--------------------------------
-Less:Other special charges ------440K--------------------------------
Other non- operating income (expenses) --------------------------113K---3M------3.12M
Income before tax 30.89%-716K-34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M
Income tax 0000000000
Net income 30.89%-716K-34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M
Net income continuous Operations 30.89%-716K-34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M
Minority interest income
Net income attributable to the parent company 30.89%-716K-34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 30.89%-716K-34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M133.58%1.34M
Basic earnings per share 0.00%-0.01-42.86%-0.1-500.00%-0.0650.00%-0.01-200.00%-0.0166.67%-0.0253.33%-0.0766.67%-0.0150.00%-0.02120.00%0.01
Diluted earnings per share 0.00%-0.01-42.86%-0.1-500.00%-0.0650.00%-0.01-200.00%-0.0166.67%-0.0253.33%-0.0766.67%-0.0150.00%-0.02120.00%0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+1.73%
Alphabet-C
GOOG
+1.16%
Alphabet-A
GOOGL
+1.13%
Vale SA
VALE
+1.01%
Coinbase
COIN
+0.67%

Unlock the Full List